Clinician's Roundtable
Tune in to interviews with the top thought leaders in medicine exploring the clinical and professional issues that are foremost in the minds of the medical community. Join us at the Clinician's Roundtable for discussions on a vast range of topics that every medical professional should know about.
61-75 of 3506
Helping Patients with IgAN Navigate Treatment Decisions
Clinician's RoundtableHelping Patients with IgAN Navigate Treatment Decisions
Sayna Norouzi, MD
The Pathologist’s Role in IgAN Management
Clinician's RoundtableThe Pathologist’s Role in IgAN Management
Anjay Rastogi, MD, PhD
Anjay Rastogi, MD, PhD
The Hidden Costs of IV-Push Controlled Substance Waste in Hospitals
Clinician's RoundtableThe Hidden Costs of IV-Push Controlled Substance Waste in Hospitals
Alexandria May, PharmD, BCPS
John B. Hertig, PharmD, MS, CPPS, FASHP, FFIP
Macitentan in Pediatric PAH: Results from the TOMORROW Trial
Clinician's RoundtableMacitentan in Pediatric PAH: Results from the TOMORROW Trial
Early Recognition and Diagnostic Confidence in NTM Lung Disease
Clinician's RoundtableEarly Recognition and Diagnostic Confidence in NTM Lung Disease
Brian P. McDonough, MD, FAAFP
Doreen Addrizzo-Harris, MD
- advertisement
Emerging Data in NTM Lung Disease: Potential Impacts and Ongoing Challenges
Clinician's RoundtableEmerging Data in NTM Lung Disease: Potential Impacts and Ongoing Challenges
Alexandria May, PharmD, BCPS
David E. Griffith, MD
Clinical Features and Outcomes of IOFB Removal
New Retina RadioClinical Features and Outcomes of IOFB Removal
Managing Severe Asthma: 2026 GINA Strategy Report Recommendations
Clinician's RoundtableManaging Severe Asthma: 2026 GINA Strategy Report Recommendations
Charles Turck, PharmD, BCPS, BCCCP
Jonathan Berstein, MD
Socioeconomic Determinants and Outcomes in Proliferative Sickle Retinopathy
Clinical Minute RetinaSocioeconomic Determinants and Outcomes in Proliferative Sickle Retinopathy
María H. Berrocal, MD
Audina Berrocal, MD
Multi-Omics Brings New Clarity to the REHAB-PH Trial
Clinician's RoundtableMulti-Omics Brings New Clarity to the REHAB-PH Trial
Optimizing Screening Pathways for Alpha-1 Antitrypsin Deficiency
Clinician's RoundtableOptimizing Screening Pathways for Alpha-1 Antitrypsin Deficiency
Alexandria May, PharmD, BCPS
Michael Czarnecki, MD
- advertisement
How to Increase Testing Rates for Alpha-1 Antitrypsin Deficiency
Clinician's RoundtableHow to Increase Testing Rates for Alpha-1 Antitrypsin Deficiency
Brian P. McDonough, MD, FAAFP
Brooks Kuhn, MD, MAS
A Phenotype-Driven Approach to Alpha-1 Antitrypsin Deficiency Care
Clinician's RoundtableA Phenotype-Driven Approach to Alpha-1 Antitrypsin Deficiency Care
Brian P. McDonough, MD, FAAFP
MeiLan Han, MD, MS
Bridging the Gap Between Evolving Science and Patient Understanding
Clinician's RoundtableBridging the Gap Between Evolving Science and Patient Understanding
Jason Goldman, MD